M. H. Bahgat
Departments of
Internal Medicine,
Mansoura University,
Egypt
N.A. Sayed- Ahmed
Departments of
Internal Medicine,
Mansoura University,
Egypt
H. El- Shinnawy
Faculty of Medicine and Student Hospital,
Mansoura University, Egypt
M.S. Nour El-Din
Department of Parasitology, Mansoura University, Egypt
K.R. Zalata
Department of Pathology, Mansoura University, Egypt
ABSTRACT
GM-CSF is an important mediator of inflammation has been used to improve the immunological function of patients with various diseases and to ameliorate hematological disorders. We aimed at studying a possible role of GM-CSF in chronic viral hepatitis and to seek a rationale for its therapeutic use in such cases. Serum GM-CSF levels were found to be significantly elevated in all patient groups versus control. This elevation was significantly correlated with histological activity index (HAI) grade in the total group of patients with hepatitis, serum transaminases and with total leucocytic count (TLC), polymorphs, lymphocytes, monocytes and eosinophils. Stepwise regression analysis showed that HAI grades as well as polymorphs are the most potent significant predictive variables for serum GMC-CSF. Patients with leucopenia had significantly lower serum GM-CSF levels. GM-CSF may have a possible role in the pathogenesis of chronic viral hepatitis possibly by increasing the number of phagocytic cells. This might propose a rationale for the use of recombinant GM-CSF in patients with chronic viral hepatitis, especially those with leucopenia.
PDF References Citation
How to cite this article
M. H. Bahgat, N.A. Sayed- Ahmed, H. El- Shinnawy, M.S. Nour El-Din and K.R. Zalata, 2001. Role of Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) in Chronic Hepatitis B and C Infections. Journal of Medical Sciences, 1: 1-7.
DOI: 10.3923/jms.2001.1.7
URL: https://scialert.net/abstract/?doi=jms.2001.1.7
DOI: 10.3923/jms.2001.1.7
URL: https://scialert.net/abstract/?doi=jms.2001.1.7
REFERENCES
- Anastassakos, C., G.J.M. Alexander, R.A. Wolstencroft, J.A. Avery and B.C. Portmann et al., 1988. Interleukin-1 and Interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology, 94: 999-1005.
CrossRefDirect Link - Barkhuizen, A., H.R. Rosen, S. Wolf, K. Flora, K. Benner and R.M. Bennett, 1999. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients. Am. J. Gastroenterol., 94: 1355-1360.
CrossRefPubMedDirect Link - Batts, K.P. and J. Ludwig, 1995. Chronic hepatitis. An update on terminology and reporting. Am. J. Surg. Pathol., 19: 1409-1417.
PubMedDirect Link - Bedossa, P., P. Bioulac-Sage, P. Callard, M. Chevallier and C. Degott et al., 1994. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology, 20: 15-20.
CrossRefPubMedDirect Link - Carreno, V., A. Parra, S. Navas and A.J. Quiroga, 1996. Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for interferon α treatment of chronic hepatitis C. Cytokine, 8: 318-322.
CrossRefDirect Link - Churchill, L., B. Friedman, R.P. Schleimer and D. Proud, 1992. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology, 75: 189-195.
Direct Link - Ishak, K., A. Baptista, L. Bianchi, F. Callea and J. De Groote et al., 1995. Histological grading and staging of chronic hepatitis. J. Hepatol., 22: 696-699.
CrossRefDirect Link - Knodell, R.G., K.G. Ishak, W.C. Black, T.S. Chen and R. Craig et al., 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1: 431-435.
CrossRefPubMedDirect Link - Kountouras, J., P. Boura and G. Tsapas, 1998. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients. Hepatogastroenterology, 45: 2295-2302.
PubMedDirect Link - Lieschke, G.J. and A.W. Burgess, 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New Engl. J. Med., 327: 28-35.
CrossRefDirect Link - Lok, A.S., I. Lindsay, P.J. Scheuer and H.C. Thomas, 1985. Clinical and histological features of delta infection in chronic hepatitis B virus carriers. J. Clin. Pathol., 38: 530-533.
CrossRefPubMedDirect Link - Ludwig, J., 1993. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology, 105: 274-278.
CrossRefPubMedDirect Link - Martin, J., O. Bosch, G. Moraleda, J. Bartolome, J.A. Quiroga and V. Carreo, 1993. Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatology, 18: 775-780.
CrossRefPubMedDirect Link - Metcalf, D., 1985. The granulocyte-macrophage colony stimulating factors. Cell, 43: 5-6.
CrossRefPubMedDirect Link - Metcalf, D., 1986. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood, 67: 257-267.
PubMedDirect Link - Quiroga, J.A., J. Martin, M. Pardo and V. Carreo, 1994. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C and their relation to therapeutic response to interferon-alpha. Dig. Dis. Sci., 39: 2485-2496.
CrossRefPubMedDirect Link - Reiser, M., C.G. Marousis, D.R. Nelson, G. Lauer, R.P. Gonzalez-Peralta, G.L. Davis and J.Y.N. Lau, 1997. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J. Hepatol., 26: 471-478.
CrossRefPubMedDirect Link - Scheuer, P.J., 1991. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol., 13: 372-374.
CrossRefDirect Link - Shiffman, M.L., C.M. Hoffman, V.A. Luketic and A.J. Sanyal, 1998. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C. J. Hepatol., 28: 382-389.
CrossRefDirect Link - Stanley, E.R., G. Hansen, J. Woodcock and D. Metcalf, 1975. Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed. Proc., 34: 2272-2278.
PubMedDirect Link - Van Thiel, D.H., L. Friedlander, R.J. Kania, P.J. Molloy, T. Hassanein and H. Faruki, 1997. A preliminary experience with GM-CSF plus interferon in patients with HBV and HCV resistant to interferon therapy. J. Viral Hepat., 1: 101-106.
CrossRefPubMedDirect Link